In a Thursday, June 14, ruling, a federal appellate court denied claims from health insurers who claimed they were owed billions of dollars from an Affordable Care Act (ACA) program. The court ruled 2-1 against two insurers who wanted the federal government to repay them for covering sicker, more expensive patients than initially expected.

Medical device company Stryker filed a claim with the Securities and Exchange Commission on Wednesday saying it is not in discussions with Boston Scientific on a potential takeover.

A federal court hearing has been scheduled regarding the Trump administration’s decision to give states the power to enforce work requirements on Medicaid enrollees.

Despite claims otherwise from President Donald Trump, the Affordable Care Act remains the law of the land—though federal actions have increased instability in the ACA’s marketplaces. Following last year’s repeal of the individual mandate, insurers are now offering short-term, non-ACA-compliant policies, which could leave a sicker, older population shopping on ACA marketplaces.

Officials from HHS are currently talking with pharmaceutical companies to pursue voluntary price cuts as part of President Donald Trump’s drug pricing plan, The Hill reports.

Five months before the 2018 midterm elections, California Republicans see their opponents’ embrace of exploring single-payer healthcare as an opportunity.

On Monday, June 11, CMS released guidance for states to leverage Medicaid in fighting opioid abuse and misuse—with the document making specific mention of efforts to reduce negative impact in infants and outlining potential benefits of health information technology.

Private equity firm KKR & Co. announced its plan to buy Envision Healthcare for $5.57 billion and debt. The all-cash transaction will value Envision at $9.9 billion, according to Bloomberg.